Aura Biosciences Inc banner

Aura Biosciences Inc
NASDAQ:AURA

Watchlist Manager
Aura Biosciences Inc Logo
Aura Biosciences Inc
NASDAQ:AURA
Watchlist
Price: 6.81 USD 1.04%
Market Cap: $432.4m

During the last 3 months Aura Biosciences Inc insiders have not bought any shares, and sold 618.8k USD worth of shares. The stock price has increased by 18% over this period (open performance analysis).

The last transaction was made on Feb 17, 2026 by Kilroy Conor , who sold 61k USD worth of AURA shares.

Last Transactions:
De Los Pinos Elisabet
$-241.1k
Elazzouzi Amy
$-43.3k
Hopkins Janet Jill
$-103.2k
Plavsic Mark
$-80.2k
Kilroy Conor
$-61k
De Los Pinos Elisabet
$-82.3k
Elazzouzi Amy
$-7.7k
Hopkins Janet Jill
$-92.7k
De Los Pinos Elisabet
$-57.5k
Elazzouzi Amy
$-5.7k
Plavsic Mark
$-77.3k
Elazzouzi Amy
$-51.7k
Gibney Anthony S
$+245k
Johnson David Michael
$+98k
Elazzouzi Amy
$-4.9k
Kilroy Conor
$-39.3k
Plavsic Mark
$-16.7k
Elazzouzi Amy
$-10.9k
Hopkins Janet Jill
$-19.6k
De Los Pinos Elisabet
$-156.8k
De Los Pinos Elisabet
$-122.4k
Elazzouzi Amy
$-7.7k
Hopkins Janet Jill
$-110.7k
De Los Pinos Elisabet
$-98.8k
Elazzouzi Amy
$-5.9k
De Los Pinos Elisabet
$-300.8k
Feder Julie B
$-302.4k
Plavsic Mark
$-72.7k
De Los Pinos Elisabet
$-121.1k
Feder Julie B
$-50.5k
Matrix Capital Management Company, Lp
$+14m
Johnson David Michael
$+70.1k
View All Transactions

During the last 3 months Aura Biosciences Inc insiders have not bought any shares, and sold 618.8k USD worth of shares. The stock price has increased by 18% over this period (open performance analysis).

The last transaction was made on Feb 17, 2026 by Kilroy Conor , who sold 61k USD worth of AURA shares.

Sold
0-3
months
618.8k USD
5
3-6
months
233.2k USD
4
6-9
months
51.7k USD
1
9-12
months
44.2k USD
2
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
2
343k USD

Aura Biosciences Inc
Insider Trading Chart

Aura Biosciences Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Aura Biosciences Inc
Last Insider Transactions

Global
Insiders Monitor

Aura Biosciences Inc
Glance View

Market Cap
432.4m USD
Industry
Biotechnology

Aura Biosciences, Inc. is a clinical-stage oncology company. The company is headquartered in Cambridge, Massachusetts and currently employs 52 full-time employees. The company went IPO on 2021-10-29. The firm operates a platform, which focuses on ocular and urologic oncology. Its platform enables targeting of a range of solid tumors using Virus-Like Particles (VLPs) that can be conjugated with drugs or loaded with nucleic acids to create Virus-Like Drug Conjugates (VDCs). The firm's VDC platform offers a range of portfolio of targeted oncology therapeutics. The company engaged in developing AU-011 for the treatment of early-stage disease, which includes small melanomas and indeterminate lesions. Its product candidate, AU-011 consists of a human papilloma virus (HPV)-derived VLP conjugated to thousands of infrared laser-activated molecules. VDC prevents the conjugation from interfering with tumor binding enabling its selectivity to specifically modified HSPGs on tumor cells but not to normal cells. In addition, the Company is developing AU-011 for the treatment of non-muscle invasive bladder cancer (NMIBC).

AURA Intrinsic Value
1.07 USD
Overvaluation 84%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett